UnitedHealth Group Incorporated UNH
376.59
1.58
0.42%
as of 25 Sep
- Market cap
- $336.8B
- P/E
- 24.2×
Follow UNH
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
UnitedHealth Group Incorporated (UNH) Return on equity
UnitedHealth Group Incorporated's return on equity over the twelve months to 30 June 2026 was 13.8%, up 1.6 percentage points from fiscal 2025 (12.2%). Over the past ten years it has ranged from 12.2% (fiscal 2025) to 25.7% (fiscal 2022) — the current reading is the lowest in ten years. That is above the Healthcare Plans industry median of 12.5% and above the Healthcare sector median of −32.0%.
Return on equity, annual
Annual
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 12.2% | (2.79) |
| FY2024 | 15.0% | (10.50) |
| FY2023 | 25.5% | (0.26) |
| FY2022 | 25.7% | 1.60 |
| FY2021 | 24.1% | 0.19 |
| FY2020 | 23.9% | (0.20) |
| FY2019 | 24.1% | 1.10 |
| FY2018 | 23.0% | (0.97) |
| FY2017 | 24.0% | 4.47 |
| FY2016 | 19.5% | 1.95 |
Against its own ten years
Low 12.2%
High 25.7%
Ten-year median
23.9%
Current reading's percentile
9
Return on equity against peers
| Company | Return on equity |
|---|---|
| OSCR Oscar Health, Inc. compare | 34.2% |
| CI Cigna Group compare | 15.4% |
| UNH UnitedHealth Group Incorporated | 13.8% |
| ELV Elevance Health, Inc. compare | 11.2% |
| HUM Humana Inc. compare | 6.81% |
| CVS CVS Health Corporation compare | 6.21% |
| MOH Molina Healthcare, Inc compare | −0.16% |
| CLOV Clover Health Investments, Corp. compare | −5.10% |
| CNC Centene Corporation compare | −20.4% |
| Healthcare Plans industry median | 12.5% |
| Healthcare sector median | −32.0% |
| Market median | 1.76% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on UNH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement